Trial Profile
Dose comparison study with palonosetron for the prevention of postoperative nausea and vomiting in children undergoing strabismus surgery
Status:
Not stated
Phase of Trial:
Phase II
Latest Information Update: 02 May 2011
Price :
$35
*
At a glance
- Drugs Palonosetron (Primary)
- Indications Postoperative nausea and vomiting
- Focus Therapeutic Use
- 02 May 2011 New trial record
- 01 Mar 2011 Results published in Drugs in R and D.